GB/T 43278-2023Medical laboratories - Application of risk management to medical laboratories (English PDF)
医学实验室 风险管理在医学实验室的应用
This is a limited preview
Buy now to download the full PDF (67 pages)
Need quotation for your management?
Get a formal quotation for GB/T 43278-2023 in 30 minutes.
Issued by
State Administration for Market Regulation, China National Standardization Administration
Level / Type
National · Recommended
Issue date
November 27, 2023
Implementation date
June 1, 2024
Scope
GB/T 43278-2023 is the English-translated version of 医学实验室 风险管理在医学实验室的应用.
GB/T 43278-2023 — This document sets out the requirements for medical laboratories to identify and manage the risks associated with their examinations for patients, laboratory staff and service providers: the process of: This process includes the identification, estimation, evaluation, control and monitoring of risks: The requirements of this document apply to all aspects of medical laboratory testing and services, including pre-inspection, inspection and post-inspection aspects: accurate transmission of test results to electronic medical records, as well as other technical and management processes included in ISO 15189: This document does not specify an acceptable level of risk: This document does not apply to the risk of clinical decisions made by medical staff after testing: This document does not apply to the management of risks affecting medical laboratory operations covered by ISO 31000, such as commercial, economic, legal and regulatory risk:
Found what you need?
Document preview — GB/T 43278-2023
National Standard of the People's Republic of China
- ICS
- 11.100.01
- Classification
- C 30
Issued by: State Administration for Market Regulation, China National Standardization Administration
Contents
- Preface
- Introduction
- 1 Scope
- 2 Normative references
- 3 Terms and Definitions
- 4 Risk Management
- 5 Risk Analysis
- 6 Risk Assessment
- 7 Risk Control
- 8 Benefit-Risk Analysis
- 9 Risk Management Review
- 10 Risk monitoring, analysis and control activities
- Appendix A (informative) Implementing risk management in the quality management system
- Appendix B (informative) Developing a risk management plan
- Appendix C (Informative) Risk Acceptability Analysis
- Appendix D (informative) Identification of safety-related characteristics
- Appendix E (informative) Examples of hazards, foreseeable sequences of events and hazardous situations
- Appendix F (informative) Non-conformities that may lead to significant risks
- Appendix G (Informative) Risk Analysis Tools and Techniques
- Appendix H (Informative) Risk Analysis of Predictable User Behavior
- Appendix I (informative) Risk assessment methods, including estimates of hazard probability and severity
- Appendix J (informative) Total residual risk assessment and risk management review
- Appendix K (informative) Conducting a benefit-risk analysis
- Appendix L (Informative) Residual Risk
- Reference
Foreword
This document complies with the provisions of GB/T 1.1-2020 "Standardization Work Guidelines Part 1: Structure and Drafting Rules of Standardization Documents" Drafting:
This document is equivalent to ISO 22367:2020 "Application of Medical Laboratory Risk Management in Medical Laboratories":
Please note that some content in this document may be subject to patents: The publisher of this document assumes no responsibility for identifying patents:
Introduction
This document provides a framework for medical laboratories whose experience, insights and judgment can be used to manage the risks associated with laboratory testing:
The risk management process covers the full scope of medical laboratory services: pre-test, test and post-test processes, including the design and development:
ISO 15189 requires medical laboratories to review their work processes, assess the impact of potential failures on test results, and modify processes to reduce or Eliminate identified risks and document decisions and actions taken: This document describes the process for managing these security risks, focusing on patient not only operators and other personnel, equipment and other property, but also the environment: It does not address business operations covered by ISO 31000 risk:
Medical laboratories often rely on the use of in vitro medical devices to achieve their quality goals: Therefore, risk management is essential for in vitro diagnostic medical devices the shared responsibility of the (IVD) manufacturer and the medical laboratory: Since most IVD manufacturers have implemented YY/T 0316-2016, this article this document uses the same concepts, principles and framework as YY/T 0316-2016 to manage risks associated with medical laboratories:
Medical laboratory activities expose patients, staff or other interested parties to a variety of hazards that may directly or indirectly result in varying degrees of harm: The concept of risk has two components:
a) Probability of hazard occurrence;
b) The consequences of the hazard, that is, the possible severity of the hazard:
Risk management is complex because each stakeholder may assign different weights to the risk of harm: This document and ISO 14971 is consistent with the Global Harmonization Task Force (GHTF) guidance and is intended to facilitate laboratories, IVD manufacturers, regulatory agencies, accreditation bodies, and others Risk communication and collaboration among stakeholders benefit patients, laboratories, and public health:
Medical laboratories are accustomed to focusing on detection errors, which are usually the result of use errors in daily work: Usage errors possible it is due to poor design of the instrument working interface or insufficient information provided by the manufacturer; it may also be caused by reasonably foreseeable misuse, such as Intentional failure to follow the IVD manufacturer's instructions for use or failure to follow generally accepted medical laboratory practices: These errors may cause or lead to dangerous Risks may appear immediately as independent events, or they may appear multiple times throughout the system, or they may remain latent until other secondary events:
occur: The emerging field of usability engineering treats all of these "human factors" as preventable "usage errors:" In addition, the laboratory needs Respond to occasional failures when IVD medical devices operate as intended: Risks arising from equipment failure and usage errors, regardless of the cause can be proactively managed:
Risk management is integrated with quality management in many elements of ISO 15189, in particular complaints management, internal audits, corrective actions, Preventive measures, safety checklists, quality control, management reviews, external reviews (including accreditation and proficiency testing): At the same time, risk management and medicine the laboratory has consistent safety management, such as the safety checklist in ISO 15190:
Risk management is a planned and systematic process that is best implemented through a structured framework: This document is intended to assist medical laboratories Integrate risk management into its daily organization, operations and management:
medical laboratory
Application of risk management in medical laboratories
1 Scope
This document sets out the requirements for medical laboratories to identify and manage the risks associated with their examinations for patients, laboratory staff and service providers:
the process of: This process includes the identification, estimation, evaluation, control and monitoring of risks:
The requirements of this document apply to all aspects of medical laboratory testing and services, including pre-inspection, inspection and post-inspection aspects:
accurate transmission of test results to electronic medical records, as well as other technical and management processes included in ISO 15189:
This document does not specify an acceptable level of risk:
This document does not apply to the risk of clinical decisions made by medical staff after testing:
This document does not apply to the management of risks affecting medical laboratory operations covered by ISO 31000, such as commercial, economic, legal and regulatory risk:
2 Normative reference documents
This document has no normative references:
3 Terms and definitions
The following terms and definitions apply to this document:
ISO and IEC maintain terminology databases used for standardization at:
---ISO online browsing platform: available at https://www:iso:org/obp;
benefit
The positive impact or desired outcome of a process (3:19), procedure (3:17) or use of a medical device on an individual's health, or on patient management or the public positive effects on health:
Note: Benefits include increased lifespan, reduced pain (symptom relief), improved function, or better health:
eventevent
The occurrence or change of a certain type of situation:
Note 1: An event may be the occurrence of one or more circumstances and may be caused by multiple reasons:
Note 2: Events may include situations that did not occur:
Note 3: Events may sometimes be referred to as "incidents" or "accidents":
Note 4: Events without consequences may also be referred to as "near misses", "accidents", "imminent harm" or "near misses":
[Source: GB/T 23694-2013,4:5:1:3] 3.3 examination A set of operations for the purpose of determining the value or characteristics of a property:
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 67 pages — is available in the English PDF.
How to Download GB/T 43278-2023
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 10003-2026 — Biaxially oriented polypropylene (BOPP) film
GB/T 10004-2026 — Plastic/Plastic laminated films and pouches for packaging
GB/T 10007-2026 — Rigid cellular plastics - Determination of shear properties
Secure payment via Stripe
Payments accepted
GB/T 43278-2023
$890.00